Antiphospholipid antibody in localised scleroderma

Annals of the Rheumatic Diseases

Volumn 62, Issue 8, 2003, Pages 771-774

  Sato, S ^a   Fujimoto, M ^b   Hasegawa, M ^a   Takehara, K ^a  

^a KANAZAWA UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCE   (Japan)

^b NATIONAL CENTER FOR GLOBAL HEALTH AND MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; BETA2 GLYCOPROTEIN 1 ANTIBODY; CARDIOLIPIN ANTIBODY; HISTONE ANTIBODY; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INTERLEUKIN 6; LUPUS ANTICOAGULANT; PHOSPHOLIPID ANTIBODY; RHEUMATOID FACTOR; SINGLE STRANDED DNA;

ADULT; ANTIBODY DETECTION; ANTIBODY SCREENING; ARTICLE; BLOOD CLOTTING TEST; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC VALUE; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; LUNG EMBOLISM; MALE; MORPHEA; PREVALENCE; PRIORITY JOURNAL; SCLERODERMA; SYSTEMIC SCLEROSIS;

ADULT; ANTIBODIES, ANTICARDIOLIPIN; ANTIBODIES, ANTIPHOSPHOLIPID; BETA 2-GLYCOPROTEIN I; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GLYCOPROTEINS; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; LUPUS COAGULATION INHIBITOR; MALE; MIDDLE AGED; SCLERODERMA, LOCALIZED; SCLERODERMA, SYSTEMIC;

EID: 0038336739     PISSN: 00034967     EISSN: None     Source Type: Journal    
DOI: 10.1136/ard.62.8.771     Document Type: Article

References (15)

1. Sato S, Fujimoto M, Ihn H, Kikuchi K, Takehara K. Clinical characteristics associated with antihistone antibodies in patients with localized scleroderma. J Am Acad Dermatol 1994;31:567-71.
2. Sato S, Ihn H, Soma Y, Igarashi A, Tamaki T, Kikuchi K, et al. Antihistone antibodies in patients with localized scleroderma. Arthritis Rheum 1993;36:1137-41.
3. Sato S, Fujimoto M, Ihn H, Kikuchi K, Takehara K. Antigen specificity of antihistone antibodies in localized scleroderma. Arch Dermatol 1994;130:1273-7.
4. Merrill JT, Shen C, Gugnani M, Lahita RG, Mongey AB. High prevalence of antiphospholipid antibodies in patients taking procainamide. J Rheumatol 1997;24:1083-8.
5. Hess EV. Is there a phospholipid specificity of lupus anticoagulants (LAC) in patients with autoimmune and drug induced LAC? J Rheumatol 1998;25:200-2.
6. Canoso RT, de Oliveira RM. Chlorpromazine-induced anticardiolipin antibodies and lupus anticoagulant: absence of thrombosis. Am J Hematol 1988;27:272-5.
7. ARA. Subcommittee for Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 1980;23:581-90.
8. LeRoy EC, Black C, Fleischmajer R, Jablonska S, Krieg T, Medsger Jr TA, et al. Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol 1988;15:202-5.
9. Brandt JT, Triplett DA, Alving B, Scharrer I. Criteria for the diagnosis of lupus anticoagulants: an update. On behalf of the Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibody of the Scientific and Standardisation Committee of the ISTH. Thromb Haemost 1995;74:1185-90.
10. Renaudineau Y, Grunebaum E, Krause I, Praprotnik S, Revelen R, Youinou P, et al. Anti-endothelial cell antibodies (AECA) in systemic sclerosis increased sensitivity using different endothelial cell substrates and association with other autoantibodies. Autoimmunity 2001;33:171-9.
11. Rowell NR, Tate GM. Failure to demonstrate the lupus anticoagulant in systemic sclerosis. Br J Dermatol 1988;119:549.
12. Tan EM. Antinuclear antibodies: diagnostic markers for autoimmune diseases and probes for cell biology. Adv Immunol 1989;44:93-151.
13. Gastineau DA, Holcomb GR. Lupus anticoagulant in drug-induced systemic lupus erythematosus (SLE). Arch Intern Med 1985;145:1926-7.
14. Drouvalakis KA, Buchanan RR. Phospholipid specificity of autoimmune and drug induced lupus anticoagulants; association of phosphatldylethanolamine reactivity with thrombosis in autoimmune disease. J Rheumatol 1998;25:290-5.
15. Oger E, Lernyer C, Dueymes M, Le Moigne E, Bressolette L, Escoffre M, et al. Association between IgM anticardiolipin antibodies and deep venous thrombosis in patients without systemic lupus erythematosus. Lupus 1997;6:455-61.